Masimo Corp MASI recently announced that its SedLine brain function monitor has been selected by Penn Highlands DuBois, a health centre with one of the best hospital safety scores (according to ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® brain function monitoring for pediatric patients (1-18 years of age). With ...

Masimo CorpMASI recently announced that its SedLine brain function monitor has been selected by Penn Highlands DuBois, a health centre with one of the best hospital safety scores (according to ...

The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. SedLine helps clinicians monitor ...

(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...

IRVINE, Calif., July 13 Masimo (Nasdaq: MASI), the inventor of Masimo Rainbow Pulse CO-Oximetry(TM), Masimo Rainbow Acoustic Monitoring(TM), and Masimo SET® Measure-Through Motion and Low Perfusion ...

Masimo (NASDAQ: MASI) announced today that it has received CE Mark for its SEDLine brain function monitor - expanding access to and availability of SEDLine's advanced neuromonitoring technology to ...

Next Generation SedLine Now Available for Use on Patients 1-18 Years Old in CE Mark Countries NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® ...

Next Generation SedLine enhances how Masimo’s processed EEG parameter, the Patient State Index (PSI), responds in challenging situations, addressing many of the concerns raised with quantitative EEG ...

IRVINE, Calif., Jan. 12 Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced a strategic investment totaling $3.5 ...